Who gets Lung cancer?

Isimgħu din il-paġna

Min ikollu l- kanċer tal- pulmun?

Il- kanċer tal- pulmun jistaʼ jaffettwa lil kulħadd, imma ċerti fatturi jistgħu jżidu r- riskju li tiżviluppa l- marda.

Dawn jinkludu:

1. It- tipjip: It- tipjip huwa l- kawża ewlenija tal- kanċer tal- pulmun.

Iktar ma persuna tpejjep għal żmien twil u iktar ma tpejjep sigaretti, akbar hu r- riskju tagħha.

2. It- tipjip passiv: L- espożizzjoni għat- tipjip passiv tistaʼ wkoll iżżid ir- riskju taʼ kanċer tal- pulmun.

3. Il- gass radon: L- espożizzjoni għall- gass radon, gass radjuattiv li jseħħ b'mod naturali u li jistaʼ jakkumula fid- djar, tistaʼ żżid ir- riskju taʼ kanċer tal- pulmun.

4. Asbestos u karċinoġeni oħra: L- espożizzjoni għall- asbestos, l- arseniku, il- kromju, in- nikil, u sustanzi oħra tistaʼ żżid ir- riskju taʼ kanċer tal- pulmun.

5. Tniġġis tal-arja: Espożizzjoni fit-tul għat-tniġġis tal-arja tista' żżid ir-riskju ta' kanċer tal-pulmun.

6. Storja tal- familja: Storja tal- familja taʼ kanċer tal- pulmun tistaʼ żżid ir- riskju taʼ persuna.

7. L- età: Ir- riskju taʼ kanċer tal- pulmun jiżdied mal- età, u l- biċċa l- kbira mill- każijiet iseħħu f'nies li għandhom iktar minn 65 sena.

8. Is-sess: L-irġiel huma aktar probabbli li jiżviluppaw kanċer tal-pulmun mill-nisa.

9. Storja personali ta ' mard tal- pulmun: Persuni b' storja ta ' mard tal- pulmun bħall- marda obstrutiva kronika tal- pulmun (COPD) jew it- tuberkulożi jistgħu jkollhom riskju akbar ta ' kanċer tal- pulmun.

10. Terapija bir- radjazzjoni fis- sider: Nies li kellhom terapija bir- radjazzjoni fis- sider għal kanċer ieħor għandhom riskju akbar taʼ kanċer tal- pulmun.

Huwa importanti li wieħed jinnota li mhux kulħadd b' fatturi ta ' riskju se jiżviluppa kanċer tal- pulmun, u xi nies li jiżviluppaw kanċer tal- pulmun jistgħu ma jkollhom l- ebda fatturi ta ' riskju magħrufa.

Referenzi

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Couraud S, Grolleau E: [How to implement lung cancer screening ?] Rev Prat. 2020, 70 (8): 864-867.

Casutt A, Lovis A, Selby K, Noirez L, Peters S, Beigelman-Aubry C, Krueger T, Soccal PM, Von Garnier C: [Lung cancer screening in Switzerland : Who ? How ? When ?] Rev Med Suisse. 2020, 16 (715): 2224-2226.

Peres J: Lung cancer screening gets risk-specific. J Natl Cancer Inst. 2013, 105 (1): 1-2.

McNeil C: Combined therapy for lung cancer gets a boost. J Natl Cancer Inst. 1996, 88 (17): 1182-4.

Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, Contesso G, Le M: Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat. 2002, 75 (1): 15-24.

Ali Mohammed Hammamy R, Farooqui K, Ghadban W: Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. Case Rep Med. 2018, 2018 (): 1903757.

Wu J, Ma L, Wang J, Qiao Y: [Mechanism of Ferroptosis and Its Research Progress in Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2020, 23 (9): 811-817.

Cancer Screening Gets Thumbs-up From Readers. Manag Care. 2017, 26 (5): 30-31.

Tneħħija ta ' responsabbiltà: mediku

Dan is-sit tal-web huwa pprovdut għal skopijiet edukattivi u ta' informazzjoni biss u ma jikkostitwixxix l-għoti ta' parir mediku jew servizzi professjonali.

L- informazzjoni pprovduta m'għandhiex tintuża għad- dijanjosi jew it- trattament taʼ problema jew marda tas- saħħa, u dawk li jfittxu parir mediku personali għandhom jikkonsultaw maʼ tabib liċenzjat.

Jekk jogħġbok innota li n-netwerk newrali li jiġġenera t-tweġibiet għall-mistoqsijiet, huwa speċjalment mhux preċiż meta niġu għal kontenut numeriku. Pereżempju, in-numru ta' nies dijanjostikati b'marda speċifika.

Dejjem fittex il-parir tat-tabib tiegħek jew ta' fornitur tas-saħħa kwalifikat ieħor dwar kundizzjoni medika. Qatt ma tinjora l-parir mediku professjonali jew id-dewmien fit-tfittxija tiegħu minħabba xi ħaġa li qrajt f'dan il-websajt. Jekk taħseb li tista' jkollok emerġenza medika, ċempel 911 jew mur l-eqreb kamra tal-emerġenza immedjatament. L-ebda relazzjoni bejn tabib u pazjent ma tinħoloq minn dan il-websajt jew l-użu tagħha. La BioMedLib u lanqas l-impjegati tagħha, u lanqas kwalunkwe kontributur għal dan il-websajt, ma jagħmel xi rappreżentazzjonijiet, espressi jew impliċiti, fir-rigward tal-informazzjoni pprovduta hawnhekk jew għall-użu tagħha.

Riżerva ta' responsabbiltà: drittijiet tal-awtur

L-Att dwar id-Drittijiet tal-Awtur tal-Millennju Diġitali tal-1998, 17 U.S.C. § 512 (il-"DMCA") jipprovdi rikors għas-sidien tad-drittijiet tal-awtur li jemmnu li materjal li jidher fuq l-Internet jikser id-drittijiet tagħhom skont il-liġi tad-drittijiet tal-awtur tal-Istati Uniti.

Jekk temmen b'bona fidi li kwalunkwe kontenut jew materjal magħmul disponibbli b'rabta mal-websajt jew is-servizzi tagħna jikser id-drittijiet tal-awtur tiegħek, inti (jew l-aġent tiegħek) tista' tibgħatilna avviż li jitlob li l-kontenut jew il-materjal jitneħħa, jew li l-aċċess għalih jiġi mblukkat.

L-avviżi għandhom jintbagħtu bil-miktub bil-posta elettronika (ara t-taqsima "Kuntatt" għall-indirizz tal-posta elettronika).

Id-DMCA teħtieġ li n-notifika tiegħek ta' ksur allegat tad-drittijiet tal-awtur tinkludi l-informazzjoni li ġejja: (1) deskrizzjoni tax-xogħol protett bid-drittijiet tal-awtur li huwa s-suġġett ta' ksur allegat; (2) deskrizzjoni tal-kontenut allegatament li jikser id-drittijiet tal-awtur u informazzjoni suffiċjenti biex inkunu nistgħu nsibu l-kontenut; (3) informazzjoni ta' kuntatt għalik, inkluż l-indirizz tiegħek, in-numru tat-telefon u l-indirizz tal-email; (4) dikjarazzjoni minnek li għandek twemmin ta' fidi tajba li l-kontenut bil-mod li dwaru l-ilment ġie ppreżentat mhuwiex awtorizzat mid-detentur tad-drittijiet tal-awtur, jew mill-aġent tiegħu, jew mill-operazzjoni ta' kwalunkwe liġi;

(5) stqarrija minnek, iffirmata taħt il-piena ta' perjuri, li l-informazzjoni fin-notifika hija preċiża u li għandek l-awtorità li tinforza d-drittijiet tal-awtur li huma ddikjarati li ġew miksura;

u (6) firma fiżika jew elettronika tas-sid tad-drittijiet tal-awtur jew ta' persuna awtorizzata li taġixxi f'isem is-sid tad-drittijiet tal-awtur.

In-nuqqas li tinkludi l-informazzjoni kollha ta' hawn fuq jista' jwassal għal dewmien fit-trattament tal-ilment tiegħek.

Kuntatt

Jekk jogħġbok ibgħatilna email b'kull mistoqsija / suġġeriment.

Who gets lung cancer?

Lung cancer can affect anyone, but certain factors can increase the risk of developing the disease.

These include:

1. Smoking: Smoking is the leading cause of lung cancer.

The longer a person smokes and the more cigarettes they smoke, the greater their risk.

2. Secondhand smoke: Exposure to secondhand smoke can also increase the risk of lung cancer.

3. Radon gas: Exposure to radon gas, a naturally occurring radioactive gas that can accumulate in homes, can increase the risk of lung cancer.

4. Asbestos and other carcinogens: Exposure to asbestos, arsenic, chromium, nickel, and other substances can increase the risk of lung cancer.

5. Air pollution: Long-term exposure to air pollution can increase the risk of lung cancer.

6. Family history: A family history of lung cancer may increase a person's risk.

7. Age: The risk of lung cancer increases with age, with most cases occurring in people over the age of 65.

8. Gender: Men are more likely to develop lung cancer than women.

9. Personal history of lung disease: People with a history of lung diseases such as chronic obstructive pulmonary disease (COPD) or tuberculosis may have an increased risk of lung cancer.

10. Radiation therapy to the chest: People who have had radiation therapy to the chest for other cancers have an increased risk of lung cancer.

It is important to note that not everyone with risk factors will develop lung cancer, and some people who do develop lung cancer may not have any known risk factors.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.